Skip to content

Zoetis ZTS Companion Animal — Revenue

Other product segments

Horses
$5.8B+13.9%
Dogs and Cats
$1.35B+11.6%
Parasiticides
$586M+2.4%
Vaccines
$519M+18.2%
Cattle
$399M-0.5%
Dermatology
$349M-7.9%
Anti-infectives
$241M+1.3%
Pain and sedation
$203M-1.9%
Other pharmaceutical
$158M0.0%
Swine
$128M-7.9%
Animal health diagnostics
$117M+12.5%
Poultry
$117M-7.9%
Other Non Pharmaceuticals
$66M-7.0%
Fish
$65M+4.8%
Contract manufacturing & human health
$23M-23.3%
Sheep and other
$17M+6.3%

Similar metrics at other companies

Tractor Supply Company logo
TSCOCompanion Animal — Sales Revenue Net Percentage
26%-1.0pp
Elanco Animal Health Inc. logo
ELANPet Health — Revenue
$710M+11.8%
Central Garden & Pet Company logo
CENTDog & cat products — Revenue
$148.2M-1.3%
Petco Health and Wellness Company, Inc. logo
WOOFSupplies And Companion Animals — Revenue
$481.26M-2.5%
Central Garden & Pet Company logo
CENTOther pet products — Revenue
$150.65M-5.1%
Elanco Animal Health Inc. logo
ELANFarm Animal: — Revenue
$642M+17.6%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$31.9B-54.6%
Enterprise value$39.95B-47.2%
P/E12.1×-15.1×
P/S3.4×-4.1×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's companion animal — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's companion animal — revenue?
Zoetis (ZTS) reported companion animal — revenue of $1.52B in Q1 2026.
How has Zoetis's companion animal — revenue changed year-over-year?
Zoetis's companion animal — revenue decreased by 1.4% year-over-year, from $1.54B to $1.52B.
What is the long-term trend for Zoetis's companion animal — revenue?
Over 4 years (2021 to 2025), Zoetis's companion animal — revenue has grown at a 8.8% compound annual growth rate (CAGR), from $4.69B to $6.58B.
What does companion animal — revenue mean?
This metric represents the total gross sales generated from products and services specifically designed for companion animals, such as dogs, cats, and horses. It serves as a primary indicator of the company's market penetration and demand within the pet health and wellness sector, which typically exhibits different growth drivers and cyclicality compared to livestock or production animal segments. This revenue stream is a critical component of the firm's overall top-line performance and reflects the success of its portfolio in the high-margin pet healthcare market.